190 related articles for article (PubMed ID: 21304496)
1. Apolipoprotein B knockdown by AAV-delivered shRNA lowers plasma cholesterol in mice.
Koornneef A; Maczuga P; van Logtenstein R; Borel F; Blits B; Ritsema T; van Deventer S; Petry H; Konstantinova P
Mol Ther; 2011 Apr; 19(4):731-40. PubMed ID: 21304496
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic expression of hairpins targeting apolipoprotein B100 induces phenotypic and transcriptome changes in murine liver.
Maczuga P; Verheij J; van der Loos C; van Logtenstein R; Hooijer G; Martier R; Borel F; Lubelski J; Koornneef A; Blits B; van Deventer S; Petry H; Konstantinova P
Gene Ther; 2014 Jan; 21(1):60-70. PubMed ID: 24152580
[TBL] [Abstract][Full Text] [Related]
3. Embedding siRNA sequences targeting apolipoprotein B100 in shRNA and miRNA scaffolds results in differential processing and in vivo efficacy.
Maczuga P; Lubelski J; van Logtenstein R; Borel F; Blits B; Fakkert E; Costessi A; Butler D; van Deventer S; Petry H; Koornneef A; Konstantinova P
Mol Ther; 2013 Jan; 21(1):217-27. PubMed ID: 23089734
[TBL] [Abstract][Full Text] [Related]
4. siRNA-induced liver ApoB knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipids.
Tadin-Strapps M; Peterson LB; Cumiskey AM; Rosa RL; Mendoza VH; Castro-Perez J; Puig O; Zhang L; Strapps WR; Yendluri S; Andrews L; Pickering V; Rice J; Luo L; Chen Z; Tep S; Ason B; Somers EP; Sachs AB; Bartz SR; Tian J; Chin J; Hubbard BK; Wong KK; Mitnaul LJ
J Lipid Res; 2011 Jun; 52(6):1084-1097. PubMed ID: 21398511
[TBL] [Abstract][Full Text] [Related]
5. An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis.
Crooke RM; Graham MJ; Lemonidis KM; Whipple CP; Koo S; Perera RJ
J Lipid Res; 2005 May; 46(5):872-84. PubMed ID: 15716585
[TBL] [Abstract][Full Text] [Related]
6. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1.
Nakamuta M; Chang BH; Zsigmond E; Kobayashi K; Lei H; Ishida BY; Oka K; Li E; Chan L
J Biol Chem; 1996 Oct; 271(42):25981-8. PubMed ID: 8824235
[TBL] [Abstract][Full Text] [Related]
7. Effective lowering of plasma, LDL, and esterified cholesterol in LDL receptor-knockout mice by adenovirus-mediated gene delivery of ApoB mRNA editing enzyme (Apobec1).
Teng B; Ishida B; Forte TM; Blumenthal S; Song LZ; Gotto AM; Chan L
Arterioscler Thromb Vasc Biol; 1997 May; 17(5):889-97. PubMed ID: 9157952
[TBL] [Abstract][Full Text] [Related]
8. The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice: effects on plasma lipoproteins and the development of atherosclerotic lesions.
Fu T; Mukhopadhyay D; Davidson NO; Borensztajn J
J Biol Chem; 2004 Jul; 279(27):28662-9. PubMed ID: 15123680
[TBL] [Abstract][Full Text] [Related]
9. Reduction of choroidal neovascularization in mice by adeno-associated virus-delivered anti-vascular endothelial growth factor short hairpin RNA.
Askou AL; Pournaras JA; Pihlmann M; Svalgaard JD; Arsenijevic Y; Kostic C; Bek T; Dagnaes-Hansen F; Mikkelsen JG; Jensen TG; Corydon TJ
J Gene Med; 2012 Nov; 14(11):632-41. PubMed ID: 23080553
[TBL] [Abstract][Full Text] [Related]
10. Safe and sustained overexpression of functional apolipoprotein A-I/high-density lipoprotein in apolipoprotein A-I-null mice by muscular adeno-associated viral serotype 8 vector gene transfer.
Cimmino G; Chen W; Speidl WS; Giannarelli C; Ibanez B; Fuster V; Hajjar R; Walsh CE; Badimon JJ
J Cardiovasc Pharmacol; 2009 Nov; 54(5):405-11. PubMed ID: 19701094
[TBL] [Abstract][Full Text] [Related]
11. Effects of dietary fats and cholesterol on liver lipid content and hepatic apolipoprotein A-I, B, and E and LDL receptor mRNA levels in cebus monkeys.
Hennessy LK; Osada J; Ordovas JM; Nicolosi RJ; Stucchi AF; Brousseau ME; Schaefer EJ
J Lipid Res; 1992 Mar; 33(3):351-60. PubMed ID: 1314879
[TBL] [Abstract][Full Text] [Related]
12. Liver LDL receptor mRNA expression is decreased in human ApoB/CETP double transgenic mice and is regulated by diet as well as the cytokine oncostatin M.
Liu J; Zhang YL; Spence MJ; Vestal RE; Wallace PM; Grass DS
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2948-54. PubMed ID: 9409281
[TBL] [Abstract][Full Text] [Related]
13. Hammerhead ribozyme as a therapeutic agent for hyperlipidemia: production of truncated apolipoprotein B and hypolipidemic effects in a dyslipidemia murine model.
Enjoji M; Wang F; Nakamuta M; Chan L; Teng BB
Hum Gene Ther; 2000 Nov; 11(17):2415-30. PubMed ID: 11096445
[TBL] [Abstract][Full Text] [Related]
14. Development of gene therapy for treatment of age-related macular degeneration.
Askou AL
Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
[TBL] [Abstract][Full Text] [Related]
15. In vivo regulation of low-density lipoprotein receptor and apolipoprotein B gene expressions by dietary fat and cholesterol in inbred strains of mice.
Srivastava RA; Jiao S; Tang JJ; Pfleger BA; Kitchens RT; Schonfeld G
Biochim Biophys Acta; 1991 Oct; 1086(1):29-43. PubMed ID: 1683257
[TBL] [Abstract][Full Text] [Related]
16. Adeno-associated virus serotype 8 gene therapy leads to significant lowering of plasma cholesterol levels in humanized mouse models of homozygous and heterozygous familial hypercholesterolemia.
Kassim SH; Li H; Bell P; Somanathan S; Lagor W; Jacobs F; Billheimer J; Wilson JM; Rader DJ
Hum Gene Ther; 2013 Jan; 24(1):19-26. PubMed ID: 22985273
[TBL] [Abstract][Full Text] [Related]
17. Phenotype interaction of apobec-1 and CETP, LDLR, and apoE gene expression in mice: role of apoB mRNA editing in lipoprotein phenotype expression.
Nakamuta M; Taniguchi S; Ishida BY; Kobayashi K; Chan L
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):747-55. PubMed ID: 9598833
[TBL] [Abstract][Full Text] [Related]
18. ApoB siRNA-induced liver steatosis is resistant to clearance by the loss of fatty acid transport protein 5 (Fatp5).
Ason B; Castro-Perez J; Tep S; Stefanni A; Tadin-Strapps M; Roddy T; Hankemeier T; Hubbard B; Sachs AB; Michael Flanagan W; Kuklin NA; Mitnaul LJ
Lipids; 2011 Nov; 46(11):991-1003. PubMed ID: 21826528
[TBL] [Abstract][Full Text] [Related]
19. The bridging function of hepatic lipase clears plasma cholesterol in LDL receptor-deficient "apoB-48-only" and "apoB-100-only" mice.
Dichek HL; Qian K; Agrawal N
J Lipid Res; 2004 Mar; 45(3):551-60. PubMed ID: 14679168
[TBL] [Abstract][Full Text] [Related]
20. Studies on the expression of genes encoding apolipoproteins B100 and B48 and the low density lipoprotein receptor in nonhuman primates. Comparison of dietary fat and cholesterol.
Sorci-Thomas M; Wilson MD; Johnson FL; Williams DL; Rudel LL
J Biol Chem; 1989 May; 264(15):9039-45. PubMed ID: 2722816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
